Ironwood Pharmaceuticals | IRWD - Ebitda



Ironwood Pharmaceuticals reported $32.05M in EBITDA for its fiscal quarter ending in December of 2024.


Ebitda Change Date
Acadia Pharmaceuticals USD 35.31M 13.07M Jun/2025
Agios Pharmaceuticals USD -125797000 20.45M Jun/2025
Almirall EUR 76.3M 8.43M Mar/2025
Alnylam Pharmaceuticals USD 18.83M 13.65M Jun/2025
Amarin USD -16025000 714K Mar/2025
Ardelyx USD -11872000 20.51M Jun/2025
Astellas Pharma JPY 140.34B 29.56B Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Charles River Laboratories USD 220.89M 2.01M Jun/2025
Exact Sciences USD 138.22M 173.88M Jun/2025
Halozyme Therapeutics USD 225.5M 63.51M Jun/2025
Incyte USD 581.52M 358.87M Jun/2025
Ironwood Pharmaceuticals USD 32.05M 5.89M Dec/2024
MacroGenics USD -33437000 17.35M Jun/2025
Moderna USD -760000000 164M Jun/2025
Myriad Genetics USD -17800000 15.7M Mar/2025
Pacira USD 54.32M 24.98M Jun/2025
PTC Therapeutics USD 971.14M 970.07M Mar/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Takeda JPY 366.2B 238.06B Jun/2025
Ultragenyx Pharmaceutical USD -91344000 35.09M Jun/2025